Keeping pace with the increasing demand for high quality drug candidates in pharmaceutical research: Development of a new two-step preparative tandem high performance chromatographic system for the purification of antibodies
Abstract In the area of biological drug development, high throughput (HT) technologies are key to identifying the most promising therapeutic candidate in a time-efficient and market-competitive manner. While efficient cloning and expression methods exist, HT downstream processing mainly relies on l...
Abstract In the area of biological drug development, high throughput (HT) technologies are key to identifying the most promising therapeutic candidate in a time-efficient and market-competitive manner. While efficient cloning and expression methods exist, HT downstream processing mainly relies on liquid handling workstations applying miniaturized chromatography columns or resin-based 96-well plates to shorten process development time. However, there is still a lack of generic, preparative chromatographic methods devoid of aggregates and endotoxins with sufficient throughput. The only truly generic antibody purification strategy including an efficient dimer removal consists of Protein A capture followed by size exclusion chromatography (SEC) as a polishing step. Other polishing methods, including IEX, HIC, and CHT, require an antibody-specific fine tuning. However, standard preparative SEC setups tend to be rather time-consuming, and so limit throughput. In this work, we devised a unique chromatography setup enabling an unattended two-step purification of IgGs on the milligram scale directly from 35 mL clarified cell supernatants, processing up to 48 samples in 44.0 h. By introducing a silica-based SEC column, preparative SEC could be accelerated. By further developing an HT two-step preparative Protein A/alternating column regeneration SEC system using Agilent 1260 Infinity LC components, mAbs can be purified generically by two chromatographic steps in 55 min. In this way, by using a 2-position/10-port valve and two quaternary pumps, two SEC columns can be run in parallel, excluding the cleaning and equilibrating phase from the actual cycle time. By further applying a third pump, the Protein A step can be run independently, resulting in a time-optimized process nesting. By introducing a CETAC ASX-520 autosampler, 48 samples can be run automatically without any user intervention over two working days. The developed system is highly reproducible for all tested human IgG1 antibodies, easily generating milligram scale material sufficient for full characterization of the antibodies and for their use in in vitro and in vivo activity assessments. Highlights HT preparative Protein A/alternating column regeneration SEC using Agilent components Optimized process nesting by parallelization of three simultaneously running pumps Introduction of a CETAC autosampler for automatic purification of 48 samples Generic purification of IgGs on milligram scale directly from clarified supernatant Integrated sample tracking and automated generation of laboratory reports
Abstract In the area of biological drug development, high throughput (HT) technologies are key to identifying the most promising therapeutic candidate in a time-efficient and market-competitive manner. While efficient cloning and expression methods exist, HT downstream processing mainly relies on liquid handling workstations applying miniaturized chromatography columns or resin-based 96-well plates to shorten process development time. However, there is still a lack of generic, preparative chromatographic methods devoid of aggregates and endotoxins with sufficient throughput. The only truly generic antibody purification strategy including an efficient dimer removal consists of Protein A capture followed by size exclusion chromatography (SEC) as a polishing step. Other polishing methods, including IEX, HIC, and CHT, require an antibody-specific fine tuning. However, standard preparative SEC setups tend to be rather time-consuming, and so limit throughput. In this work, we devised a unique chromatography setup enabling an unattended two-step purification of IgGs on the milligram scale directly from 35 mL clarified cell supernatants, processing up to 48 samples in 44.0 h. By introducing a silica-based SEC column, preparative SEC could be accelerated. By further developing an HT two-step preparative Protein A/alternating column regeneration SEC system using Agilent 1260 Infinity LC components, mAbs can be purified generically by two chromatographic steps in 55 min. In this way, by using a 2-position/10-port valve and two quaternary pumps, two SEC columns can be run in parallel, excluding the cleaning and equilibrating phase from the actual cycle time. By further applying a third pump, the Protein A step can be run independently, resulting in a time-optimized process nesting. By introducing a CETAC ASX-520 autosampler, 48 samples can be run automatically without any user intervention over two working days. The developed system is highly reproducible for all tested human IgG1 antibodies, easily generating milligram scale material sufficient for full characterization of the antibodies and for their use in in vitro and in vivo activity assessments. Highlights HT preparative Protein A/alternating column regeneration SEC using Agilent components Optimized process nesting by parallelization of three simultaneously running pumps Introduction of a CETAC autosampler for automatic purification of 48 samples Generic purification of IgGs on milligram scale directly from clarified supernatant Integrated sample tracking and automated generation of laboratory reports
Methods Mol. Biol. Geertsma 1116 153 2014 10.1007/978-1-62703-764-8_11 FX cloning: a simple and robust high-throughput cloning method for protein expression
Protein Expr. Purif. Camilo 99 35 2014 10.1016/j.pep.2014.03.008 High-throughput cloning, expression and purification of glycoside hydrolases using Ligation-Independent Cloning (LIC)
Biochem. Eng. J. Al 47 2017 High-throughput screening and optimization of mixed-mode resins for human serum albumin separation with microtiter filter plate
J. Chromatogr. A Evans 1506 73 2017 10.1016/j.chroma.2017.05.041 Optimization of a micro-scale, high throughput process development tool and the demonstration of comparable process performance and product quality with biopharmaceutical manufacturing processes
Chem. Eng. Technol. Susanto 1846 2008 10.1002/ceat.200800457 High throughput screening for the design and optimization of chromatographic processes: assessment of model parameter determination from high throughput compatible data
Biotechnol. Prog. Welsh 30 3 626 2014 10.1002/btpr.1905 A practical strategy for using miniature chromatography columns in a standardized high-throughput workflow for purification development of monoclonal antibodies
J. Chromatogr. B Anal. Technol. Biomed. Life Sci. Chhatre 878 30 3067 2010 10.1016/j.jchromb.2010.09.009 An automated packed protein G micro-pipette tip assay for rapid quantification of polyclonal antibodies in ovine serum
J. Chromatogr. A Keller 1418 94 2015 10.1016/j.chroma.2015.09.038 Use of MiniColumns for linear isotherm parameter estimation and prediction of benchtop column performance
J. Chromatogr. A T. 92 2005 Fast size-exclusion chromatography-theoretical and practical considerations
J. Chromatogr. Yoo 1344 23 2014 10.1016/j.chroma.2014.04.014 Automated high-throughput protein purification using an AKTApurifier and a CETAC autosampler
J. Chromatogr. A Holenstein 1418 103 2015 10.1016/j.chroma.2015.09.040 Automated harvesting and 2-step purification of unclarified mammalian cell-culture broths containing antibodies
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.